Soc. Generale Call 40 OMV 20.12.2.../ DE000SY1EB58 /
15/11/2024 09:22:25 | Chg.+0.014 | Bid22:00:40 | Demandez à22:00:40 | Sous-jacent | Prix d'exercice | Date d'expiration | Type d'option |
---|---|---|---|---|---|---|---|
0.047EUR | +42.42% | - Bid taille: - |
- Ask la taille: - |
OMV AG | 40.00 EUR | 20/12/2024 | Call |
GlobeNewswire
26/03
Intravacc announces positive data of first in human intranasal OMV based vaccine for SARS-CoV-2
GlobeNewswire
16/01
Intravacc Awarded US$ 633K CARB-X Funding to Develop a Vaccine that Prevents Gonorrhea Infections
GlobeNewswire
14/09/2023
Intravacc Announces Review Publication of OMV-based Intranasal Vaccines for Disease Prevention
GlobeNewswire
04/12/2018
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center
GlobeNewswire
04/12/2018
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center
- La première page
- Retour
- 1
- 2
- Suivant
- La dernière page